These findings underscore that tumour-derived EVs do not merely suppress immune surveillance through PD-L1 expression but also reprogram T-cell functional states at the transcriptomic and proteomic level, highlighting their dual role in immune evasion and tumour–immune crosstalk (Padinharayil et al., 2025). This evidence concerns the gene CD274 and neoplasm.